Fiore Healthcare Advisors is a Pharmacovigilance, Patient Safety and Clinical Research consulting and advisory firm. FHA team members are experts in Clinical Research and Safety and we bring that expertise to the client setting to ensure research programs are well designed and that patient safety is maintained during development and when products are on the market.
Pharmacovigilance Consulting Excellence
We’ve walked in your shoes, sat where you sit.
Our consultants have experience as Chief Medical Officers, Heads of Safety and Heads of Clinical Research programs. We’ve run the projects and faced business challenges similar to those you face. As a results-oriented Pharmacovigilance Consulting Firm, our approach is to jump in with both feet and work with our clients to address high priority items or build what needs to be built. We don’t simply sit back and criticize or point out issues, we bring solutions.
We don’t follow a
FHA appreciates the business value and efficiency afforded by employing appropriate frameworks and learnings from case studies. A premier clinical research consultant, we take the time to understand each client situation and design the best fit solution, leveraging previous experience as needed. We are happy to discuss examples where we suggest applying approaches used before and situations we felt novel approaches made more sense.
We are an Agile team.
Our highly skilled and experienced team of health care professionals perform activities as though we are permanent members of the client team and often fill actual roles within client companies. We are an agile team who have the ability to flex quickly and leverage existing FHA resources to ensure the spectrum of needs with our clients are addressed by an individual with the most appropriate skill level. Our model alleviates the clients worry regarding internal attrition and ensures that our team will be an extension of theirs, for the entirety of the engagement.
We provide support to different types of healthcare companies including pharmaceutical, biotechnology, contract research organizations (CRO) and academic research institutions.